Evaluation and Management of Severe Leukopenia

Immediate Assessment and Management

The American College of Physicians recommends obtaining a complete blood count with manual differential immediately to calculate the ANC and assess for blasts, dysplastic changes, or other lineage abnormalities 2
The patient requires urgent evaluation for fever/infection, and bone marrow examination to rule out hematologic malignancy given the severity and age of presentation 1, 2
If fever is present with ANC <1.0 × 10⁹/L, this constitutes a medical emergency requiring immediate blood cultures and broad-spectrum antibiotics before any diagnostic workup 2
Review of medication history is crucial as drug-induced leukopenia is a common reversible cause, particularly in young patients 1

If ANC <1.0 × 10⁹/L, the patient is at high risk and requires immediate intervention, including broad-spectrum antibiotics and consideration of G-CSF 2
Avoid all invasive procedures due to infection risk 1, 2
If ANC 1.0-1.5 × 10⁹/L, close monitoring with repeat CBC in 24-48 hours is recommended, and prophylactic fluoroquinolones may be considered if prolonged neutropenia is expected 1

Bone marrow aspiration and biopsy should be performed urgently to rule out acute leukemia, myelodysplastic syndrome, or aplastic anemia 1, 2
The bone marrow evaluation must include morphologic evaluation, conventional cytogenetic analysis, flow cytometry immunophenotyping, and molecular genetic testing and FISH analysis 2

Hematologic malignancy, such as acute leukemia, should be considered and evaluated promptly, with immediate initiation of ATRA if acute promyelocytic leukemia is suspected 3, 4
Delaying empiric antibiotics in febrile neutropenia can significantly increase mortality, and invasive procedures should be avoided during severe neutropenia 1, 2

CBC with differential should be performed twice weekly initially, until etiology is determined and counts stabilize, with more frequent monitoring if the patient develops fever or clinical deterioration 1